vs
Astrana Health, Inc.（ASTH）与SSR MINING INC.（SSRM）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是SSR MINING INC.的1.8倍（$950.5M vs $521.7M），SSR MINING INC.净利率更高（34.8% vs 0.7%，领先34.1%），SSR MINING INC.同比增速更快（61.4% vs 42.9%），SSR MINING INC.自由现金流更多（$106.4M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 50.5%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
SSR Mining Inc.（前身为白银标准资源公司）总部位于美国科罗拉多州丹佛，主营金、银、铜、铅、锌矿产开采，拥有阿根廷最大的银矿，同时在美洲全境及土耳其开展矿产勘探业务。2020年与阿拉瑟黄金合并后迁至丹佛，现任总裁兼首席执行官为罗德尼·P·安塔尔。
ASTH vs SSRM — 直观对比
营收规模更大
ASTH
是对方的1.8倍
$521.7M
营收增速更快
SSRM
高出18.5%
42.9%
净利率更高
SSRM
高出34.1%
0.7%
自由现金流更多
SSRM
多$112.3M
$-6.0M
两年增速更快
ASTH
近两年复合增速
50.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $521.7M |
| 净利润 | $6.6M | $181.5M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 38.8% |
| 净利率 | 0.7% | 34.8% |
| 营收同比 | 42.9% | 61.4% |
| 净利润同比 | 184.4% | 3166.6% |
| 每股收益（稀释后） | $0.12 | $0.84 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHSSRM
| Q4 25 | $950.5M | $521.7M | ||
| Q3 25 | $956.0M | $385.8M | ||
| Q2 25 | $654.8M | $405.5M | ||
| Q1 25 | $620.4M | $316.6M | ||
| Q4 24 | $665.2M | $323.2M | ||
| Q3 24 | $478.7M | $257.4M | ||
| Q2 24 | $486.3M | $184.8M | ||
| Q1 24 | $404.4M | $230.2M |
净利润ASTHSSRM
| Q4 25 | $6.6M | $181.5M | ||
| Q3 25 | $373.0K | $65.4M | ||
| Q2 25 | $9.4M | $90.1M | ||
| Q1 25 | $6.7M | $58.8M | ||
| Q4 24 | $-7.8M | $5.6M | ||
| Q3 24 | $16.1M | $10.6M | ||
| Q2 24 | $19.2M | $9.7M | ||
| Q1 24 | $14.8M | $-287.1M |
营业利润率ASTHSSRM
| Q4 25 | 1.9% | 38.8% | ||
| Q3 25 | 2.0% | 21.6% | ||
| Q2 25 | 3.1% | 26.9% | ||
| Q1 25 | 3.3% | 21.1% | ||
| Q4 24 | 0.1% | 10.6% | ||
| Q3 24 | 5.9% | 3.5% | ||
| Q2 24 | 6.2% | 5.8% | ||
| Q1 24 | 7.5% | -163.5% |
净利率ASTHSSRM
| Q4 25 | 0.7% | 34.8% | ||
| Q3 25 | 0.0% | 17.0% | ||
| Q2 25 | 1.4% | 22.2% | ||
| Q1 25 | 1.1% | 18.6% | ||
| Q4 24 | -1.2% | 1.7% | ||
| Q3 24 | 3.4% | 4.1% | ||
| Q2 24 | 3.9% | 5.2% | ||
| Q1 24 | 3.7% | -124.7% |
每股收益（稀释后）ASTHSSRM
| Q4 25 | $0.12 | $0.84 | ||
| Q3 25 | $0.01 | $0.31 | ||
| Q2 25 | $0.19 | $0.42 | ||
| Q1 25 | $0.14 | $0.28 | ||
| Q4 24 | $-0.14 | $0.03 | ||
| Q3 24 | $0.33 | $0.05 | ||
| Q2 24 | $0.40 | $0.05 | ||
| Q1 24 | $0.31 | $-1.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $575.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $3.5B |
| 总资产 | $2.2B | $6.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHSSRM
| Q4 25 | $429.5M | $575.6M | ||
| Q3 25 | $463.4M | $445.4M | ||
| Q2 25 | $342.1M | $438.5M | ||
| Q1 25 | $260.9M | $341.3M | ||
| Q4 24 | $290.8M | $417.3M | ||
| Q3 24 | $350.3M | $365.8M | ||
| Q2 24 | $327.7M | $384.4M | ||
| Q1 24 | $337.3M | $492.0M |
总债务ASTHSSRM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $228.6M | ||
| Q3 24 | — | $228.3M | ||
| Q2 24 | — | $228.0M | ||
| Q1 24 | — | $228.7M |
股东权益ASTHSSRM
| Q4 25 | $779.3M | $3.5B | ||
| Q3 25 | $775.5M | $3.3B | ||
| Q2 25 | $765.5M | $3.3B | ||
| Q1 25 | $745.4M | $3.2B | ||
| Q4 24 | $712.7M | $3.1B | ||
| Q3 24 | $704.6M | $3.1B | ||
| Q2 24 | $678.9M | $3.1B | ||
| Q1 24 | $653.5M | $3.1B |
总资产ASTHSSRM
| Q4 25 | $2.2B | $6.1B | ||
| Q3 25 | $2.2B | $5.9B | ||
| Q2 25 | $1.4B | $5.8B | ||
| Q1 25 | $1.3B | $5.6B | ||
| Q4 24 | $1.4B | $5.2B | ||
| Q3 24 | $1.3B | $5.1B | ||
| Q2 24 | $1.3B | $5.2B | ||
| Q1 24 | $1.2B | $5.3B |
负债/权益比ASTHSSRM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.07× | ||
| Q3 24 | — | 0.07× | ||
| Q2 24 | — | 0.07× | ||
| Q1 24 | — | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $172.1M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $106.4M |
| 自由现金流率自由现金流/营收 | -0.6% | 20.4% |
| 资本支出强度资本支出/营收 | 0.3% | 12.6% |
| 现金转化率经营现金流/净利润 | -0.44× | 0.95× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $241.6M |
8季度趋势，按日历期对齐
经营现金流ASTHSSRM
| Q4 25 | $-2.9M | $172.1M | ||
| Q3 25 | $10.0M | $57.2M | ||
| Q2 25 | $90.9M | $157.8M | ||
| Q1 25 | $16.6M | $84.8M | ||
| Q4 24 | $-10.9M | $95.0M | ||
| Q3 24 | $34.0M | $-1.3M | ||
| Q2 24 | $23.2M | $-78.1M | ||
| Q1 24 | $6.0M | $24.6M |
自由现金流ASTHSSRM
| Q4 25 | $-6.0M | $106.4M | ||
| Q3 25 | $7.4M | $-2.4M | ||
| Q2 25 | $89.5M | $98.4M | ||
| Q1 25 | $13.6M | $39.3M | ||
| Q4 24 | $-13.5M | $56.4M | ||
| Q3 24 | $31.7M | $-34.1M | ||
| Q2 24 | $20.4M | $-116.3M | ||
| Q1 24 | $5.6M | $-9.4M |
自由现金流率ASTHSSRM
| Q4 25 | -0.6% | 20.4% | ||
| Q3 25 | 0.8% | -0.6% | ||
| Q2 25 | 13.7% | 24.3% | ||
| Q1 25 | 2.2% | 12.4% | ||
| Q4 24 | -2.0% | 17.5% | ||
| Q3 24 | 6.6% | -13.2% | ||
| Q2 24 | 4.2% | -62.9% | ||
| Q1 24 | 1.4% | -4.1% |
资本支出强度ASTHSSRM
| Q4 25 | 0.3% | 12.6% | ||
| Q3 25 | 0.3% | 15.4% | ||
| Q2 25 | 0.2% | 14.7% | ||
| Q1 25 | 0.5% | 14.4% | ||
| Q4 24 | 0.4% | 11.9% | ||
| Q3 24 | 0.5% | 12.7% | ||
| Q2 24 | 0.6% | 20.7% | ||
| Q1 24 | 0.1% | 14.8% |
现金转化率ASTHSSRM
| Q4 25 | -0.44× | 0.95× | ||
| Q3 25 | 26.69× | 0.87× | ||
| Q2 25 | 9.65× | 1.75× | ||
| Q1 25 | 2.48× | 1.44× | ||
| Q4 24 | — | 17.10× | ||
| Q3 24 | 2.11× | -0.13× | ||
| Q2 24 | 1.21× | -8.06× | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SSRM
| Gold | $369.3M | 71% |
| Concentrate Sales | $124.4M | 24% |
| Other | $19.1M | 4% |
| Lead | $9.0M | 2% |
